financetom
Business
financetom
/
Business
/
Market Chatter: Paramount in Talks to Sell BET Network for $1.6 Billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Paramount in Talks to Sell BET Network for $1.6 Billion
Jul 2, 2024 11:46 AM

02:27 PM EDT, 07/02/2024 (MT Newswires) -- Paramount Global ( PARAA ) is having discussions to sell its Black Entertainment Television network for $1.6 billion to $1.7 billion, Bloomberg reported, citing people familiar with the matter.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 10.54, Change: +0.40, Percent Change: +3.94

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Investors Title Company Maintains Dividend at $0.46 per Share; Payable Sept. 16 to Shareholders of Record on Sept. 3
--Investors Title Company Maintains Dividend at $0.46 per Share; Payable Sept. 16 to Shareholders of Record on Sept. 3
Aug 13, 2024
03:28 AM EDT, 08/13/2024 (MT Newswires) -- Price: 202.45, Change: -0.10, Percent Change: -0.05 ...
Annexon Files Registration Statement on Behalf of Selling Shareholders
Annexon Files Registration Statement on Behalf of Selling Shareholders
Aug 13, 2024
03:27 AM EDT, 08/13/2024 (MT Newswires) -- Annexon ( ANNX ) filed a registration statement Monday covering the potential sale of up to 3 million common shares to be offered by certain selling shareholders. The company said it is not selling any of its shares and will not receive proceeds from the secondary offering. Price: 5.52, Change: -0.09, Percent Change:...
Citius Pharmaceuticals Completes Merger of Oncology Subsidiary With Blank Check Firm TenX Keane
Citius Pharmaceuticals Completes Merger of Oncology Subsidiary With Blank Check Firm TenX Keane
Aug 13, 2024
03:41 AM EDT, 08/13/2024 (MT Newswires) -- Citius Pharmaceuticals ( CTXR ) said late Monday it has completed the pending merger of its oncology subsidiary and blank check firm TenX Keane Acquisition (TENK). The combined company has been renamed Citius Oncology ( TENK ), with its stock expected to debut on Nasdaq on Aug. 13 under the ticker, CTOR. Pursuant...
Kyverna Therapeutics Says FDA Grants Regenerative Medicine Advanced Therapy Designation to Autoimmune Disorder Drug
Kyverna Therapeutics Says FDA Grants Regenerative Medicine Advanced Therapy Designation to Autoimmune Disorder Drug
Aug 13, 2024
03:35 AM EDT, 08/13/2024 (MT Newswires) -- Kyverna Therapeutics ( KYTX ) said late Monday the US Food and Drug Administration has granted regenerative medicine advanced therapy designation to its KYV-101 experimental therapy, which is being developed to treat progressive myasthenia gravis. Myasthenia gravis is an autoimmune disorder associated with muscle weakness. The designation allows Kyverna to leverage on more...
Copyright 2023-2026 - www.financetom.com All Rights Reserved